Cart
sales@molnova.com
6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethyl]chromone
CAS No. 1802143-09-4
6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethyl]chromone( ——— )
Catalog No. M38758 CAS No. 1802143-09-4
6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethyl]chromone
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethyl]chromone
-
NoteResearch use only, not for human use.
-
Brief Description6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethyl]chromone
-
Description6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethyl]chromone
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1802143-09-4
-
Formula Weight326.3
-
Molecular FormulaC19H18O5
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Protosappanin B
Protosappanin B significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43.
-
Emicizumab
Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
-
Methyl-2-Butyl-Butyr...
Methyl-2-Butyl-Butyrate (2-methylbutyl butyrate) is a RIFM flavor.
